House Democrat Places Hold on Trump's $2.8 Billion Heavy-Bomb Sale to Israel

Meeks says he will not clear the sale at this time

Meeks announced the hold through the Democratic staff of the House Foreign Affairs Committee. He said the proposed package raises unresolved questions about compliance with U.S. and international law and the protection of civilians.

The New York Democrat said his decision does not diminish congressional support for Israel's legitimate defense needs. He framed the hold as an oversight action intended to ensure that U.S.-funded weapons are used lawfully and responsibly.

Those statements explain Meeks' position; they do not establish that the proposed weapons have already been used unlawfully. No reviewed source reports that the newly proposed package has been delivered or used in combat.

The hold delays clearance but does not kill the deal

Major proposed arms transfers typically enter an informal tiered-review process in which the State Department consults the top lawmakers on congressional foreign-affairs committees before formally notifying Congress. Meeks' refusal to clear the package interrupts that customary process.

Meeks cannot unilaterally prohibit the transfer. Reuters reports that the president may proceed if the administration determines that an emergency requires an immediate sale. The administration used an emergency determination to expedite another Israel arms transfer in 2025.

Congress could attempt to block a formally notified sale through a joint resolution of disapproval, but overcoming a presidential veto would require two-thirds support in both chambers. No such resolution has passed, and the proposed sale has not been permanently canceled.

The reported package contains 40,000 heavy bombs

The administration's proposal covers 40,000 2,000-pound bombs, according to Meeks' official statement and Reuters. The original Reuters report described 20,000 MK-84 and 20,000 BLU-117 general-purpose bomb bodies.

Two-thousand-pound bombs are among the most destructive conventional munitions in the U.S. arsenal. Meeks said their potential use in densely populated parts of Gaza and Lebanon is central to his concern about civilian casualties and legal safeguards.

The $2.8 billion proposal remains under review. A proposed quantity is not proof that 40,000 bombs have been contracted, shipped or delivered, and no reviewed source provides a delivery schedule.

A previous sale shows why procedural precision matters

In February 2025, the Defense Security Cooperation Agency publicly announced a separate possible $2.04 billion sale to Israel involving MK-84 or BLU-117 bomb bodies and related equipment. That notice said the secretary of state had made a determination and Congress had received the required certification.

The current $2.8 billion proposal is separate. The earlier notice helps identify the weapon class and demonstrates what a formal public notification can contain, but it does not confirm the approval status, financing or delivery schedule of the new package.

The precise confirmed status is limited: Meeks has placed an informal hold and says he will not clear the sale now; the administration retains routes to proceed; no reviewed source establishes that the package is formally approved, permanently blocked or already delivered.

About the image

The featured image is an authentic August 2017 U.S. Air Force photograph by Senior Airman Justin Parsons showing personnel guiding an MK-84 bomb body onto a munitions assembly conveyor during training at Beale Air Force Base in California. As a U.S. government work, it is in the public domain.

The file photograph identifies the weapon type discussed in the Reuters report. It does not depict Israel, Gaza, the 2026 proposal, a congressional review, a delivery or combat use, and its inclusion does not imply Air Force endorsement of this publication.